Innoprot

Innoprot is a privately held, revenue-generating Spanish CRO and product company serving the global biopharma research sector. Its core business model combines the sale of specialized research products (like primary cells and engineered cell lines) with fee-for-service contract research, particularly in cell line development and phenotypic/target-based assay services. The company's technology focuses on creating advanced cellular models for drug discovery in areas such as oncology, CNS disorders, fibrosis, and metabolic diseases, positioning it as a specialized tools and services provider in the pre-clinical research space.

Platform for primary cell isolation, stable cell line engineering (including immortalization, knockdown, fluorescent tagging), and development of phenotypic & target-based cell assays for drug discovery.

Innoprot competes in a fragmented market with large, diversified life science tools companies (e.g., Thermo Fisher Scientific, Sartorius) and many small-to-mid sized specialized CROs and cell line providers (e.g., ATCC, Creative Bioarray, numerous regional players). Its differentiation lies in its specific assay portfolio and custom cell engineering services focused on complex phenotypic models.